Individuals with long COVID may have a higher risk for abnormal blood clotting, especially those who have difficulties with basic exercise for more than 12 weeks after infection, according to a study published in Blood Advances.
The findings highlight a potential role for antithrombotic therapy in the management of these patients, researchers noted.
Long COVID, characterized by persistent fatigue, reduced exercise tolerance, chest pain, shortness of breath and cognitive slowing, is an increasingly recognized complication of acute COVID-19 infection, according to Nithya Prasannan, researcher in